Skip to content
Partnership for Safe Medicines
  • News
    • Diabetes & Weight-loss Injectables
    • Fake HIV Medications
    • PBMs
    • Botox / Botulism warning
    • Illegal Pill Presses
    • Fake Adderall
    • Poisonous cough syrup
    • Social Media & Fake Pills
    • Counterfeit Pill Crisis
  • Patients
    • Learn about Counterfeits and to Save Money Safely
    • The Drug Importation Debate
    • Drug Counterfeiters Get Light Sentences
    • Real Victims of Counterfeit Drugs
    • Talk to Your Family
    • HIV/HEPC Patients
    • Mexican Pharmacies
  • Professionals
    • Pharmacists
    • Doctors
    • Law Enforcement
    • Educators
    • Prosecution Document Library
    • Research On Drug Safety
  • Policy
    • Publications
    • Pharmaceutical Border Security
    • Drug Importation
    • PBM under-reimbursement
    • Illegal Pill Presses
    • Affordability Boards (PDABs)
    • Alternative funding programs (AFPs)
    • Pharmacy-to-pharmacy marketplaces
    • FOIA-ed Materials
    • Events, briefings, and op-eds
  • About Us
    • Join Our Mailing List
    • Members
    • PSM Leadership
    • Press Releases
    • Contact Us

Posts Tagged ‘Op-ed-CO-SB19’

Colorado’s Canadian Rx import plan fuels counterfeit Ozempic dangers

May 29, 2024

Executive Director Shabbir Safdar’s editorial ran on May 15, 2024 in Colorado Politics

[...]

“…barriers will delay or prevent drug importation,” say regulatory experts

October 14, 2020

In this analysis, which was published in Lexology on October 13, 2020, three global regulatory experts examine barriers to drug importation.

[...]

“These drugs would go through additional shipping, inspection and repackaging. Why would they be cheaper?”

September 2, 2020
Sarah Ruth Bates

In this editorial, which was published in WBUR’s Cognoscenti on September 2, 2020, writer Sarah Ruth Bates explains why Canadian drug importation is too expensive and elaborate a solution to be effective.

[...]

Canadian patient advocate urges American friends to reject the “empty promises” of importation

August 14, 2020
Photo of patient advocate John Adams

In this August 14, 2020 editorial, Best Medicines Coalition chair John Adams explains why Canadian importation will not lower U.S. medicine prices—and why the “concept of cheap drugs from Canada has never been anything more than a political hallucination.”

[...]

Former FDA Associate Commissioner Warns of the “Massive Safety Risks of Importation”

March 3, 2020

Source: Twitter This editorial by Peter J. Pitts was published in The Times Weekly on March 3, 2020. Mr. Pitts is president of the Center for Medicine in the Public Interest and a former FDA associate commissioner. Keep Canadian drugs out of U.S. medicine cabinets The Trump administration recently proposed two rules that would allow…

[...]

Canadian drug importation is “an economic fantasy,” former Canadian health minister says.

March 2, 2020
photo of Ujjal Dosanjh

In this editorial in The Globe and Mail, Ujjal Dosanjh, formerly a federal minister of health and a premier of British Columbia, explains that drug manufacturers have no incentive to sell Canadian provinces more medicine to fill the needs of U.S. residents. Importation will lead to drug shortages in Canada and counterfeit drug trafficking to the U.S.

[...]

Canadian health law experts predict: Canada won’t end up as the drugstore to the U.S.

January 16, 2020

This editorial by David C. Rosenbaum and Dara Jospé was published in the Financial Post on January 16, 2020. Rosenbaum is a partner of the law firm Fasken. Jospé is an associate for the same company.

[...]

Academic Warns That State Drug Importation Proposals Threaten Patients and Innovation

January 10, 2020

This editorial by Dr. Kristina M. L. Acri née Lybecker was published in IP Watchdog on January 2, 2020. Dr. Acri is an Associate Professor of Economics at Colorado College in Colorado Springs, and Chair of the Department of Economics and Business.

[...]

Emory Health Policy Professor Says Drug Importation a Danger to Patient Health

October 8, 2019

This editorial by Dr. Kenneth E. Thorpe was published in Town Hall on October 8, 2019. Dr. Thorpe is a professor of health policy at Emory University and chairman of the Partnership to Fight Chronic Disease.

[...]

Pharmacy professor: buying prescription drugs from Canada “risky in terms of quality and safety”

September 27, 2019
photo of the author, C. Michael White

This editorial by C. Michael White was published in The Conversation on September 27, 2019. White is a professor and head of the Department of Pharmacy Practice for the University of Connecticut.

[...]
Older Posts »
© 2003-2023 Partnership for Safe Medicines
Click here to contact us.
Facebook Twitter Linkedin Youtube Instagram Email
Scroll To Top